Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (51-60 of 205) with videos related to

Pageof 21
Sort By:
Hepatic Oncology|September 8, 2018
Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver diseasePierre Nahon, Angela Sutton, Marianne Ziol, et al.
Gut and Liver|July 8, 2025
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical modelsRomain Desert, Fabio Gianonne, Antonio Saviano, et al.
BMC Gastroenterology|October 20, 2012
Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinomaValentyn Usachov, Pierre Nahon, Mariia Lunova, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2026
Radiological Loco-Regional Treatments for Cholangiocarcinoma: A Systematic Review of the LiteratureDimitrios Pallas, Claudia Campani, Olivier Sutter, et al.
World Journal of Gastroenterology|January 13, 2016
Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applicationsRoland Amathieu, Mohamed Nawfal Triba, Corentine Goossens, et al.
Clinics and Research in Hepatology and Gastroenterology|October 31, 2019
TIPS for management of portal-hypertension-related complications in patients with cirrhosisManon Allaire, Aurélie Walter, Olivier Sutter, et al.
BMJ Open|February 17, 2024
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancerPierre Nahon, Maxime Ronot, Olivier Sutter, et al.
Antioxidants & Redox Signaling|August 3, 2010
Do genetic variations in antioxidant enzymes influence the course of hereditary hemochromatosis?Pierre Nahon, Angela Sutton, Dominique Pessayre, et al.
World Journal of Gastroenterology|January 22, 2008
Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2009
Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control studyPierre Nahon, Adrien Kettaneh, Maud Lemoine, et al.
Pageof 21

Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
Hepatic Oncology|September 8, 2018
Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver diseasePierre Nahon, Angela Sutton, Marianne Ziol, et al.
Gut and Liver|July 8, 2025
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical modelsRomain Desert, Fabio Gianonne, Antonio Saviano, et al.
BMC Gastroenterology|October 20, 2012
Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinomaValentyn Usachov, Pierre Nahon, Mariia Lunova, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2026
Radiological Loco-Regional Treatments for Cholangiocarcinoma: A Systematic Review of the LiteratureDimitrios Pallas, Claudia Campani, Olivier Sutter, et al.
World Journal of Gastroenterology|January 13, 2016
Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applicationsRoland Amathieu, Mohamed Nawfal Triba, Corentine Goossens, et al.
Clinics and Research in Hepatology and Gastroenterology|October 31, 2019
TIPS for management of portal-hypertension-related complications in patients with cirrhosisManon Allaire, Aurélie Walter, Olivier Sutter, et al.
BMJ Open|February 17, 2024
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancerPierre Nahon, Maxime Ronot, Olivier Sutter, et al.
Antioxidants & Redox Signaling|August 3, 2010
Do genetic variations in antioxidant enzymes influence the course of hereditary hemochromatosis?Pierre Nahon, Angela Sutton, Dominique Pessayre, et al.
World Journal of Gastroenterology|January 22, 2008
Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2009
Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control studyPierre Nahon, Adrien Kettaneh, Maud Lemoine, et al.
Pageof 21